Eyeworld Daily News

52 | EYEWORLD DAILY NEWS | MAY 17, 2020 DAILY NEWS ASCRS VIRTUAL ANNUAL MEETING materials. Dr. Kretz introduced the comparison among: • PanOptix (n=10): A hydro- phobic acrylic with a total diameter of 13 mm and optical diameter of 6 mm. It is a panfocal, trifocal, aspher- ical optic with a 360-degree sharp rear optical edge. It is +2.17 D at intermediate and +3.25 D for near, and it has blue and purple light filters. • POD F (PhysIOL, n=10): A hydrophilic acrylic with a 11.4 mm total diameter and 6 mm optical zone. Its design is biconvex, aspherical, trifo- cal diffractive. It is +1.75 D (intermediate) and +3.5 D (near) with UV and blue light filters. • POD F GF (PhysIOL, n=10): A hydrophobic acrylic, glis- tening-free lens that has a 11.4 mm total diameter and 6 mm optical zone. Its de- sign, add, and filters are the same as the POD F. Dr. Kretz presented the 3- and 6-month data. The results were comparable among the three groups, especially in the PhysIOL groups. PanOptix was slightly weaker at 70 cm, com- pared to the other two, and all lenses saw spectacle indepen- dence. The research is ongoing out to 12 months, and Dr. Kretz said a larger study group is needed for more meaningful results. Find more information on these studies and others in SPS-207. Editors' note: Dr. Blehm's study was supported by a grant from Alcon. Dr. Yeu has financial interests with Alcon. Dr. Kretz has financial inter- ests with PhysIOL. Dr. Lui has no related financial interests. compared to 9% with monofo- cals. Overall, 83.5% of PanOptix recipients achieved a compos- ite binocular UCVA of 20/25 or better at distance, interme- diate, and near, compared to 8.15% of monofocal patients. Hui Liu, MD, PhD, Cheng- du, China, presented research on the objective and subjective visual quality with a trifocal in high myopes and those with different axial lengths. There were three groups for axial lengths (AL): less than 26 mm, between 26–28 mm, and great- er than 28 mm. Each group included about 20 eyes, Dr. Liu said. The AT LISA 839 tri MP (Carl Zeiss Meditec) was used. Patients who had more than 1 D of corneal astigmatism were corrected with preoperative femtosecond laser. Ultimately, the researchers found that this trifocal in highly myopic eyes could provide at least short- term patient satisfaction and refractive outcomes. Near vi- sion was decreased in low-light conditions in extremely myopic eyes, and this was associated with lower objective optical quality. Another paper by Florian Kretz, MD, Rheine, Germany, compared outcomes from three different trifocal IOLs with different optic designs and Elizabeth Yeu, MD, Norfolk, Virginia, presented a study that looked at binocular PanOptix. This research evaluated the cumulative binocular visual outcomes of PanOptix com- pared to the AcrySof monofocal SN60AT (Alcon). The study, a prospective, multicenter, non- randomized, parallel-group, assessor-masked confirmatory trial, included 243 patients who self-selected the IOL (129 PanOptix, 114 SN60AT). Those who received the PanOptix lens had similar bin- ocular distance VA compared to those with the monofocal lens. BCDVA of 20/25 or better was achieved in all patients at 6 months, and UCDVA of 20/25 was achieved in 92.1% of Pan- Optix patients and 94.6% of monofocal patients. At inter- mediate (66 cm), there was a statistically significant higher number of those achieving 20/25 or better DCIVA in the PanOptix group (97.6%) com- pared to the monofocal group (26.1%); 93.7% of PanOptix recipients achieved 20/25 or better UCIVA compared to 50.5% of monofocal recipients. At near (40 cm), 96.1% of Pan- Optix patients achieved DCNVA of 20/25 or better compared to none in the monofocal group, and 92.1% achieved UCNVA of 20/25 or better with PanOptix by Liz Hillman Editorial Co-Director A wealth of research on trifocal IOLs was in- cluded in on-demand presentations at the ASCRS Virtual Annual Meeting. One such paper presen- tation evaluated spectacle independence achieved after bilateral trifocal (AcrySof PanOptix, Alcon) IOL im- plantation, presented by Clayton Blehm, MD, Gaines- ville, Georgia. The research was a prospective, single-arm, unmasked study of 30 patients with bilateral PanOptix implan- tation, who at 3 months postop had the following measure- ments: manifest refraction, UDVA and best CDVA at 60 cm and 40 cm, and results from the Patient-Reported Spectacle Independence Questionnaire. Early results (n=18) showed that patients had little to no need for glasses within the last 7 days. There was a low degree of glasses use at any distance, but when they were used it was primarily for "little" or "some" near work. The questionnaire also re- vealed a high degree of visual function at all distances and a high degree of satisfaction at all distances, with no subjects dissatisfied with their vision at any distance. Research papers on trifocal IOLs Experience EyeWorld 24/7 EyeWorld.org Supplements Recent articles in web-friendly format Searchable archives from 2007 to present EyeWorld Weekly news feed Trending videos Live Twi•er feed

• Cover